8-K Announcements
6Material company update
Apr 22, 2026·SEC
Material company update
Apr 16, 2026·SEC
Material company update
Feb 25, 2026·SEC
AMERISAFE, Inc.(AMSF)Earnings, Financials & Key Ratios
AMSF•NASDAQ•Insurance & Managed Care
12.7× P/E·Price updated Jun 19, 2026
AboutAMERISAFE, Inc., an insurance holding company, underwrites workers' compensation insurance in the United States. The company's workers' compensation insurance policies provide benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It serves small to mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime. The company was incorporated in 1985 and is based in DeRidder, Louisiana.Show more
- Revenue$317M+2.6%
- Combined Ratio81.45%+4.9%
- Net Income$47M-15.0%
- Return on Equity18.53%-8.1%
- Medical Cost Ratio53.57%-8.5%
- Operating Margin18.55%-17.0%
- Net Margin14.86%-17.1%
- ROA4.53%-11.9%
- Equity / Assets24.36%-0.6%
AMSF Key Insights
AMERISAFE, Inc. (AMSF) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Profitable underwriting: 81.4% combined ratio
- ✓Strong Piotroski F-Score: 7/9
- ✓13 consecutive years of dividend growth
- ✓Low loss ratio of 53.6%
- ✓Good 3Y average ROE of 19.7%
✗Weaknesses
- ✗Profits declining 11.5% over 5 years
- ✗Dividend payout exceeds 100% of earnings
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when AMSF posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
AMSF Price & Volume
AMERISAFE, Inc. (AMSF) stock price & volume — 10-year historical chart
Loading chart...
AMSF Growth Metrics
AMERISAFE, Inc. (AMSF) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-2.33%
5 Years-1.35%
3 Years2.49%
TTM7.82%
Profit CAGR
10 Years-3.94%
5 Years-11.45%
3 Years-5.35%
TTM-2.36%
EPS CAGR
10 Years-3.93%
5 Years-11.19%
3 Years-4.99%
TTM-2.02%
Return on Capital
10 Years11.82%
5 Years16.53%
3 Years17.68%
Last Year16.79%
AMSF Recent Earnings
AMERISAFE, Inc. (AMSF) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
Apr 22, 2026Metric
Actual
Est
EPS
$0.50-3.8%
$0.52
Rev
$89M-2.2%
$90M
Q1 2026
Feb 25, 2026Metric
Actual
Est
EPS
$0.51-10.5%
$0.57
Rev
$70M+4.4%
$67M
Q4 2025
Oct 29, 2025Metric
Actual
Est
EPS
$0.55+0.0%
$0.55
Rev
$82M+2.4%
$80M
Q3 2025
Jul 24, 2025Metric
Actual
Est
EPS
$0.53-3.6%
$0.55
Rev
$81M+3.8%
$78M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 22, 2026 | $0.50vs $0.52-3.8% | $89Mvs $90M-2.2% |
| Q1 2026 | Feb 25, 2026 | $0.51vs $0.57-10.5% | $70Mvs $67M+4.4% |
| Q4 2025 | Oct 29, 2025 | $0.55vs $0.55+0.0% | $82Mvs $80M+2.4% |
| Q3 2025 | Jul 24, 2025 | $0.53vs $0.55-3.6% | $81Mvs $78M+3.8% |
Based on last 12 quarters of dataView full earnings history →
AMSF Peer Comparison
AMERISAFE, Inc. (AMSF) competitors in Specialty Commercial P&C Carriers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 KNTK | 3.2B | 46.53 | 17.69 | 18.98% | 13.17% | 10.9% | 1.32 | |
 EIG | 1.09B | 46.55 | 103.44 | -2.55% | 0.95% | 0.83% | 0.04 | |
 ACGL | 32.48B | 91.18 | 7.85 | 14.27% | 22.07% | 19.02% | 0.11 | |
 HIG | 35.27B | 128.25 | 9.63 | 7.1% | 14.13% | 22.01% | 0.23 | |
 TRV | 66.56B | 307.81 | 11.22 | 5.17% | 12.88% | 19.12% | 0.28 | |
 WRB | 25.16B | 67.18 | 15.10 | 7.82% | 12.1% | 18.86% | 0.29 | |
 SIGI | 5.55B | 92.31 | 12.34 | 9.78% | 8.39% | 12.93% | 0.25 | |
 CINF | 26.5B | 170.20 | 11.22 | 11.41% | 21.34% | 17.98% | 0.06 |
Compare AMSF vs Peers
AMERISAFE, Inc. (AMSF) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AMSF Income Statement
AMERISAFE, Inc. (AMSF) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 375.21M | 377.75M | 370.37M | 339.5M | 316.01M | 294.69M | 306.91M | 309.11M | 317.25M | 324.76M |
Revenue Growth % | -5.41% | 0.68% | -1.95% | -8.33% | -6.92% | -6.75% | 4.15% | 0.72% | 2.63% | 7.82% |
Medical Costs & Claims | 234.14M | 231.05M | 201.35M | 0 | 160.8M | 152.32M | 0 | 181.02M | 169.94M | 170.16M |
Medical Cost Ratio % | 62.4% | 61.16% | 54.37% | 0% | 50.88% | 51.69% | 0% | 58.56% | 53.57% | 52.4% |
Gross Profit | 141.07M▲ 0% | 146.7M▲ 4.0% | 169.02M▲ 15.2% | 339.5M▲ 100.9% | 155.22M▼ 54.3% | 142.38M▼ 8.3% | 306.91M▲ 115.6% | 128.09M▼ 58.3% | 147.31M▲ 15.0% | 154.57M▲ 0% |
Gross Margin % | 37.6% | 38.84% | 45.63% | 100% | 49.12% | 48.31% | 100% | 41.44% | 46.43% | 47.59% |
Gross Profit Growth % | -17.69% | 3.99% | 15.21% | 100.87% | -54.28% | -8.27% | 115.56% | -58.26% | 15.01% | - |
Operating Expenses | 58.83M | 59.12M | 53.5M | 232.59M | 75.77M | 74.73M | 229.53M | 59.04M | 88.46M | 96.78M |
OpEx / Revenue % | 15.68% | 15.65% | 14.45% | 68.51% | 23.98% | 25.36% | 74.79% | 19.1% | 27.88% | 29.8% |
Depreciation & Amortization | 984K | 996K | 942K | 0 | 1.02M | 1.31M | 1.43M | 1.09M | 742K | 528K |
Combined Ratio % | 78.08% | 76.82% | 68.81% | 68.51% | 74.86% | 77.05% | 74.79% | 77.66% | 81.45% | 82.19% |
Operating Income | 82.24M▲ 0% | 87.58M▲ 6.5% | 115.52M▲ 31.9% | 106.92M▼ 7.4% | 79.45M▼ 25.7% | 67.65M▼ 14.9% | 77.38M▲ 14.4% | 69.06M▼ 10.8% | 58.85M▼ 14.8% | 57.79M▲ 0% |
Operating Margin % | 21.92% | 23.18% | 31.19% | 31.49% | 25.14% | 22.95% | 25.21% | 22.34% | 18.55% | 17.79% |
Operating Income Growth % | -27.11% | 6.49% | 31.9% | -7.44% | -25.69% | -14.86% | 14.39% | -10.75% | -14.78% | - |
EBITDA | 83.22M | 88.58M | 116.46M | 106.92M | 80.47M | 68.95M | 78.8M | 70.15M | 59.59M | 58.32M |
EBITDA Margin % | 22.18% | 23.45% | 31.44% | 31.49% | 25.46% | 23.4% | 25.68% | 22.69% | 18.78% | 17.96% |
Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 | 0 | 78.8M | 0 | 0 | 0 |
Pretax Income | 82.24M▲ 0% | 87.58M▲ 6.5% | 115.52M▲ 31.9% | 106.92M▼ 7.4% | 79.45M▼ 25.7% | 67.65M▼ 14.9% | 77.38M▲ 14.4% | 69.06M▼ 10.8% | 58.85M▼ 14.8% | 57.79M▲ 0% |
Pretax Margin % | 21.92% | 23.18% | 31.19% | 31.49% | 25.14% | 22.95% | 25.21% | 22.34% | 18.55% | 17.79% |
Income Tax | 36.01M | 15.95M | 22.83M | 20.32M | 13.69M | 12.04M | 15.27M | 13.62M | 11.71M | 11.45M |
Effective Tax Rate % | 43.79% | 18.21% | 19.76% | 19% | 17.23% | 17.8% | 19.73% | 19.72% | 19.89% | 19.81% |
Net Income | 46.23M▲ 0% | 71.63M▲ 54.9% | 92.69M▲ 29.4% | 86.6M▼ 6.6% | 65.76M▼ 24.1% | 55.6M▼ 15.4% | 62.11M▲ 11.7% | 55.44M▼ 10.7% | 47.15M▼ 15.0% | 46.34M▲ 0% |
Net Margin % | 12.32% | 18.96% | 25.03% | 25.51% | 20.81% | 18.87% | 20.24% | 17.93% | 14.86% | 14.27% |
Net Income Growth % | -40.63% | 54.94% | 29.4% | -6.57% | -24.07% | -15.44% | 11.7% | -10.74% | -14.96% | -2.36% |
EPS (Diluted) | 2.40▲ 0% | 3.71▲ 54.6% | 4.80▲ 29.4% | 4.47▼ 6.9% | 3.39▼ 24.2% | 2.88▼ 15.0% | 3.23▲ 12.2% | 2.89▼ 10.5% | 2.47▼ 14.5% | 2.46▲ 0% |
EPS Growth % | -40.74% | 54.58% | 29.38% | -6.88% | -24.16% | -15.04% | 12.15% | -10.53% | -14.53% | -2.02% |
EPS (Basic) | 2.41 | 3.73 | 4.82 | 4.49 | 3.40 | 2.89 | 3.24 | 2.91 | 2.48 | - |
Diluted Shares Outstanding | 19.25M | 19.29M | 19.33M | 19.36M | 19.41M | 19.32M | 19.23M | 19.16M | 19.08M | 18.86M |
AMSF Balance Sheet
AMERISAFE, Inc. (AMSF) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Assets | 1.43B | 1.42B | 1.42B | 1.38B | 1.3B | 1.15B | 1.11B | 1.05B | 1.03B | 209.44M |
Asset Growth % | -0.63% | -0.96% | -0.4% | -2.16% | -6.06% | -11.36% | -3.9% | -5.27% | -1.62% | -94.55% |
Total Investment Assets | 1.13B | 1.13B | 1.13B | 1.09B | 1.01B | 888.99M | 857.79M | 788.78M | 734.86M | 4M |
Long-Term Investments | 1.13B | 1.13B | 1.13B | 1.09B | 1.01B | 888.99M | 857.79M | 788.78M | 734.86M | 2.26B |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 314.21M |
Total Current Assets | 229.79M | 202.82M | 201.77M | 218.52M | 205.82M | 183.18M | 171.54M | 186.7M | 222.87M | 530.84M |
Cash & Equivalents | 55.56M | 40.34M | 43.81M | 61.76M | 70.72M | 61.47M | 38.68M | 44.05M | 61.93M | 34.23M |
Receivables | 174.23M | 162.48M | 157.95M | 156.76M | 135.1M | 121.71M | 132.86M | 142.66M | 160.94M | 670.38M |
Other Current Assets | 432.38M | 365.56M | 345.2M | 397.94M | 379.86M | 276.88M | 271.6M | 278.66M | 0 | 7.2M |
Goodwill & Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.09M | 21.09M |
Goodwill | 0 | 1.09B | 0 | 1.06B | 987.78M | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.09M | 0 |
PP&E (Net) | 6.13M | 6.26M | 6.76M | 6.5M | 6.65M | 7.33M | 6.38M | 6.16M | 7.5M | 7.14M |
Other Assets | 42.61M | 47.5M | 45.94M | 37.63M | 42.73M | 41.31M | 43.09M | 39.68M | 18.56M | 0 |
Total Liabilities | 1.09B | 1.11B | 1.06B | 1.03B | 1B | 951.85M | 936.71M | 900.45M | 878.95M | -913.52M |
Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 491K | 0 |
Net Debt | -55.56M | -40.34M | -43.81M | -61.76M | -70.72M | -61.47M | -38.68M | -44.05M | -61.44M | -34.23M |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 0 | 0 | 0 | 0 | 801.34M | 747.85M | 687.71M | 680.77M | 700.73M | 0 |
Accounts Payable | 37.08M | 38.61M | 40.09M | 0 | 37.88M | 38.06M | 0 | 0 | 0 | 0 |
Deferred Revenue | 0 | 0 | 0 | 0 | 121.09M | 114.98M | 116.58M | 121.93M | 135.5M | 0 |
Other Current Liabilities | -41.35M | -31.67M | -26.19M | -417K | 642.36M | 594.81M | 571.13M | 558.85M | 565.23M | 0 |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Liabilities | 0 | 0 | 0 | 0 | 202.06M | 204M | 249M | 219.68M | 178.22M | -913.52M |
Total Equity | 425.42M▲ 0% | 409.76M▼ 3.7% | 430.21M▲ 5.0% | 438.82M▲ 2.0% | 399.32M▼ 9.0% | 317.43M▼ 20.5% | 292.45M▼ 7.9% | 257.34M▼ 12.0% | 251.6M▼ 2.2% | 1.12B▲ 0% |
Equity Growth % | -6.74% | -3.68% | 4.99% | 2% | -9% | -20.51% | -7.87% | -12.01% | -2.23% | 303.96% |
Shareholders Equity | 425.42M | 409.76M | 430.21M | 438.82M | 399.32M | 317.43M | 292.45M | 257.34M | 251.6M | 1.12B |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | 233.9M | 221.33M | 227.16M | 224.65M | 190.49M | 145.51M | 114.29M | 84.11M | 82.85M | 0 |
Common Stock | 204K | 205K | 205K | 206K | 206K | 207K | 207K | 207K | 208K | 208K |
Accumulated OCI | 3.61M | -832K | 12.21M | 21.02M | 13.54M | -13.83M | -7.19M | -8.88M | -3.22M | -5.67M |
Return on Equity (ROE) | 10.49% | 17.15% | 22.07% | 19.93% | 15.69% | 15.51% | 20.37% | 20.17% | 18.53% | 9.68% |
Return on Assets (ROA) | 3.21% | 5.02% | 6.54% | 6.19% | 4.9% | 4.53% | 5.49% | 5.14% | 4.53% | 5.56% |
Equity / Assets | 29.65% | 28.84% | 30.4% | 31.69% | 30.7% | 27.53% | 26.39% | 24.51% | 24.36% | 536.18% |
Debt / Equity | - | - | - | - | - | - | - | - | 0.00x | 0.00x |
Book Value per Share | 22.10 | 21.24 | 22.26 | 22.66 | 20.57 | 16.43 | 15.21 | 13.43 | 13.18 | 59.53 |
Tangible BV per Share | 22.10 | -35.27 | 22.26 | -32.27 | -30.32 | 16.43 | 15.21 | 13.43 | 12.08 | 59.53 |
AMSF Cash Flow Statement
AMERISAFE, Inc. (AMSF) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 130.81M | 98.27M | 78.82M | 63.4M | 37.98M | 28.19M | 29.84M | 24.19M | 11.07M | 10.16M |
Operating CF Growth % | 14.53% | -24.88% | -19.79% | -19.57% | -40.09% | -25.76% | 5.85% | -18.94% | -54.24% | -251.75% |
Operating CF / Revenue % | 34.86% | 26.01% | 21.28% | 18.67% | 12.02% | 9.57% | 9.72% | 7.83% | 3.49% | 3.13% |
Net Income | 46.23M | 71.63M | 92.69M | 86.6M | 65.76M | 55.6M | 62.11M | 55.44M | 47.15M | 46.34M |
Depreciation & Amortization | 984K | 996K | 942K | 1.01M | 1.02M | 1.31M | 1.43M | 1.09M | 742K | 703K |
Stock-Based Compensation | 2.02M | 2.06M | 2.35M | 3.3M | 2.32M | 2.48M | 1.56M | 2.94M | 2.91M | 2.42M |
Deferred Taxes | 12.8M | -1.46M | 872K | 1.66M | 1.27M | -1.14M | 628K | 1.4M | 372K | 364K |
Other Non-Cash Items | 14.66M | 14.41M | 3.98M | 2.87M | -5.24M | 11.44M | -4.84M | -7.34M | -6.23M | -21.13M |
Working Capital Changes | 54.11M | 10.63M | -22.02M | -32.04M | -27.14M | -41.5M | -31.04M | -29.34M | -33.86M | -18.53M |
Cash from Investing | -51.54M | -29.06M | 11.69M | 43.37M | 70.96M | 75.43M | 43.88M | 72.37M | 68.42M | 46M |
Capital Expenditures | -478K | -1.13M | -1.02M | -921K | -1.3M | -2.09M | -553K | -840K | -2.15M | -2.17M |
Acquisitions | -78.9M | -100.11M | -159.7M | -104.56M | 23K | -85.01M | -44.44M | 0 | 0 | 0 |
Purchase of Investments | -401.81M | -368.27M | -345.9M | -320.95M | -271.18M | -215.48M | -133.68M | -110.7M | -67M | -91.82M |
Sale/Maturity of Investments | 350.75M | 340.34M | 358.61M | 365.24M | 343.41M | 293M | 178.12M | 112.84M | 72.55M | 96.31M |
Other Investing | 78.9M | 100.11M | 159.7M | 104.56M | 0 | 85.01M | 44.44M | 71.07M | 65.02M | 43.69M |
Cash from Financing | -82.64M | -84.42M | -87.04M | -88.83M | -99.97M | -112.87M | -96.51M | -91.2M | -61.61M | -66.69M |
Dividends Paid | -82.64M | -84.49M | -87.02M | -88.78M | -99.93M | -100.43M | -93.31M | -85.44M | -48.61M | -48.95M |
Share Repurchases | 0 | 0 | -20K | 0 | 0 | -12.39M | -2.17M | -5.68M | -12.1M | -12.1M |
Stock Issued | 0 | 67K | 20K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debt Issuance (Net) | 0 | 0 | -47K | -50K | -44K | -58K | -91K | -85K | -85K | -64K |
Other Financing | 0 | 67K | 20K | 0 | 0 | 0 | -944K | -554K | -817K | -5.58M |
Net Change in Cash | -3.38M▲ 0% | -15.21M▼ 350.5% | 3.47M▲ 122.8% | 17.94M▲ 417.3% | 8.96M▼ 50.0% | -9.25M▼ 203.2% | -22.79M▼ 146.3% | 5.36M▲ 123.5% | 17.88M▲ 233.4% | -10.53M▲ 0% |
Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash at Beginning | 58.94M | 55.56M | 40.34M | 43.81M | 61.76M | 70.72M | 61.47M | 38.68M | 44.05M | 61.93M |
Cash at End | 55.56M | 40.34M | 43.81M | 61.76M | 70.72M | 61.47M | 38.68M | 44.05M | 61.93M | 34.23M |
Free Cash Flow | 130.33M▲ 0% | 97.14M▼ 25.5% | 77.81M▼ 19.9% | 62.48M▼ 19.7% | 36.68M▼ 41.3% | 26.11M▼ 28.8% | 29.29M▲ 12.2% | 23.35M▼ 20.3% | 8.92M▼ 61.8% | 7.99M▲ 0% |
FCF Growth % | 15.77% | -25.47% | -19.9% | -19.7% | -41.29% | -28.84% | 12.2% | -20.28% | -61.79% | -45.99% |
FCF Margin % | 34.74% | 25.72% | 21.01% | 18.4% | 11.61% | 8.86% | 9.54% | 7.55% | 2.81% | 2.46% |
FCF per Share | 6.77 | 5.04 | 4.03 | 3.23 | 1.89 | 1.35 | 1.52 | 1.22 | 0.47 | 0.42 |
AMSF Key Ratios
AMERISAFE, Inc. (AMSF) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Combined Ratio | 78.08% | 76.82% | 68.81% | 68.51% | 74.86% | 77.05% | 74.79% | 77.66% | 81.45% | 82.19% |
Medical Cost Ratio | 62.4% | 61.16% | 54.37% | 0% | 50.88% | 51.69% | 0% | 58.56% | 53.57% | 52.4% |
Return on Equity (ROE) | 10.49% | 17.15% | 22.07% | 19.93% | 15.69% | 15.51% | 20.37% | 20.17% | 18.53% | 9.68% |
Return on Assets (ROA) | 3.21% | 5.02% | 6.54% | 6.19% | 4.9% | 4.53% | 5.49% | 5.14% | 4.53% | 5.56% |
Equity / Assets | 29.65% | 28.84% | 30.4% | 31.69% | 30.7% | 27.53% | 26.39% | 24.51% | 24.36% | 536.18% |
Book Value / Share | 22.1 | 21.24 | 22.26 | 22.66 | 20.57 | 16.43 | 15.21 | 13.43 | 13.18 | 59.53 |
Debt / Equity | - | - | - | - | - | - | - | - | 0.00x | 0.00x |
Revenue Growth | -5.41% | 0.68% | -1.95% | -8.33% | -6.92% | -6.75% | 4.15% | 0.72% | 2.63% | 7.82% |
Related:AMSF Dividend History·AMSF Revenue History·AMSF Price History·AMSF P/E History·AMSF Financial Ratios·AMSF Institutional Holders
AMSF SEC Filings & Documents
AMERISAFE, Inc. (AMSF) SEC filings — annual & quarterly reports (10-K, 10-Q)
AMSF Frequently Asked Questions
AMERISAFE, Inc. (AMSF) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
AMERISAFE, Inc. (AMSF) grew revenue by 2.6% over the past year. Growth has been modest.
Yes, AMERISAFE, Inc. (AMSF) is profitable, generating $46.3M in net income for fiscal year 2025 (14.9% net margin).
Dividend & Returns
Yes, AMERISAFE, Inc. (AMSF) pays a dividend with a yield of 8.13%. This makes it attractive for income-focused investors.
AMERISAFE, Inc. (AMSF) has a return on equity (ROE) of 18.5%. This is reasonable for most industries.
Industry Metrics
AMERISAFE, Inc. (AMSF) has a combined ratio of 81.4%. A ratio below 100% indicates underwriting profitability.